Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
"Shaping the Future with Latest Advancements in Biobanking, Stem cells and Tissue Preservation"
- Biobanking 2019

Welcome message




Allied Academies invites all participants from all over the world to attend the International Conference on Stem Cells, Biobanking and Tissue Preservation to be held on December 09-10, 2019 at AbuDhabi, UAE contains poster presentations, oral talks, exhibitions, special sessions. With pleasure we are  honored to invite you all to share your views and experiences on Biobanking.
The main theme of the conference is to  shaping the Future with Latest Advancements in Biobanking and issues. The International Conference on Biobanking,Stem cells and Tissue Preservation has an key role to play in the understanding and explanation of biological specimens preservation benefits and extend of the latest knowledge and  technical advances in biobanking research, Stem Cell Technology and Tissue preservation which can be applicable for the clinical and medical sciences.
This conference plays a Global platform for biomedical companies, start-ups, clinical research divisions, professionals, specialists, consultants, doctors, scholars and students to frame new relationship and strengthen the Knowledge. This is a great opportunity for all the delegates from Universities and Institutes to interact with the top grade world class Scientists. The particular participants can confirm their participation through registerations.
Conference is being held at Abu Dhabi, which is the second most populous city in UAE which is situated on an island off Persian Gulf from the central western coast with an International Airport (AUH) being the city’s main attractive hub making it convenient  for the tourists and visitors to visit Abu Dhabi.
We hope you join us and take little time to enjoy the unique charm of this region.
Explore the evidence to make a difference.
Regards
Organizing Committee
Biobanking 2019

About Conference

About Organizers

Allied Academies is one of the leading Open Access publishers and organizers of international scientific conferences and events every year across USA, Europe & Asia. Allied Academics  has so far organized 3000+ Global Allied Academies Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharmacy, Engineering, Science, Technology and Business with 700+ peer-reviewed open access journals in basic science, health, and technology.

Why to attend?

International Conference on Stem Cells, Biobanking and Tissue Preservation gives you an opportunity to broaden your thinking and knowledge by listening to ideas and theories and recent developments in StemCells, Tissue Preservation. International Conference can give you a wonderful opportunity to meet and interact with fellow researchers, experts across the World. It also allows you to explore new cities, and meet new people

Salient features

Keynote speeches and plenary talks by researchers all over the globe

Opportunity to meet global experts in regenerative medical science

Posters, e-posters and video presentation by research community

International Certification by Organizing Committee

Publishing accepted abstract in International Journals

The study provides an in-depth analysis of the global biobanking market

Target Audience

§  Biobanking Researchers

§  Biobanking Scientists

§  Biobanking Investors

§  Biobanking Socities

§  Directors of Laboratories

§  Universities

§  Industries

§  Investigators

§  Post-Doctoral Fellows

§  Research and Diagnostic Laboratories

§  Clinical Fellows

§  Biomedical Research companies

§  Medical Devices companies

§  Pharma Companies

§  Business Entrepreneurs.

    Sessions/Tracks

    Session 1.Bio Banking
    Bio banking is a process in which samples of body fluid or tissues are collected for research use to improve health and disease. Other information’s, such as height, weight and any questions regarding health (e.g. family history and lifestyle) also be recorded to provide the context for the samples. Often the samples are kept for long time or for several years, depending on the study, so that long term future research can be carried out. The researchers may follow up the health of the participants by looking at their past and future medical records, but only if people have given them permission to do.

    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering Conferences| Tissue Engineering| Genomics Conferences | Tissue Preservation

     Session 2.Bio Banks
    The word bio bank covers all the collections of plant and animal, including human specimens.A bio bank is a type of bio repository that stores biological samples (usually human) for use in research. Since 1990 s bio banks have become an important resource in medical research. This typically handles human bio specimens—such as tissue, blood, urine and information pertaining to the donors:demography and lifestyle, history of present illness ,treatment and clinical outcomes. Bio banks can be classified in several ways. Bio banks may be classified by purpose or design. Using large collections of samples which represent tens or hundreds of thousands of individuals can help to identify disease bio markers
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
    Session 3.Bio Repository
    It is a repository that collects, processes, stores, and distributes bio specimens to support future  investigation. Bio repositories can contains specimens from all the  living organisms which study by preserving and storing samples. The main purpose of a bio repository is to maintain specimens, and required information, for future use in research. The bio repository assures the quality, and manages the accessibility and distribution or disposition of the bio specimens in its collection.
    The four main operations of a bio repository are; 
    (i) Collection 
    (ii) Processing
    (iii) Storage or Inventory
     (iv) Distribution of Biological Specimens.
    Upon delivery the tissue samples are recorded all information regarding the sample details are keyed into the laboratory information management system. Bio specimens are then processed to ensure consistency of the samples. Proper tissue preservation methodology is absolutely crucial to a bio repository. These specimens are then stored and held in their appropriate conditions. Sample holding boxes and freezers are sometimes used; however it depends on the storage requirements. For example Formalin-fixed paraffin-embedded tissue blocks can be stored at room temperature. Distribution involves retrieving the required samples from the inventory.
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
    Session 4.Bio Banking Classification
    ·         Bio banks may be classified by purpose or design.
    ·         Disease-oriented bio banks usually have a hospital connection through which they can collect samples represents a variety of diseases.
    ·         Population-based bio banks need no particular hospital connections through which they can take samples from large numbers of all kinds of people, in a general population for disease susceptibility.
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation 
    Session 5.Bio Banking for Rare Diseases
    ·         Bio banking is a necessary tool to produce human bio material for analysis. 
    ·         Analysis for disorders advantages from the supply of human bio materials through bio banks
    ·         Every sample from an individual with a rare disorder gives a high worth because it can answer a crucial analysis. 
    ·         International cooperation in biobanking is a crucial analysis to share restricted resources and come through best output as in different places of rare disorder analysis. 
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
     Session 6.Bio Banking for Tissues
    It is a strategic activity for research. It procures high quality of samples for research. Tissue collection protocols are required for bio markers and molecular targets for therapy. Validation of a potential bio marker requires applying ex vivo analyses within study designs with adequate epidemiological and statistical power these studies may be constructed using retrospective or prospective collections
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
     Session 7.Storage for Bio Banks
    ·         Bio banks, like DNA databases, must carefully store 
    ·         The document should access to samples and donor information. 
    ·         The samples should be maintained  with minimal deterioration they must be protected from damages like accidental and intentional. 
    ·         The entering and exiting of the sample in system is carefully stored
    ·         The location of each sample is noted so as  to allow the location of each specimens
    ·         Archival systems de-identify samples to respect the privacy of donors and allow blinding of researchers to analysis
    ·         The data is kept separately with a secure method further can link to clinical information to tissue samples
    ·         Current systems are small and are capable of storing nearly 40,000 samples in about one tenth of the space required by a 80 °C to 112 °F freezer.
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
     Session 8.Bio Banks Ethics and Issues
    ·         Key ethical issues in biobanking represents
    Ø  Respecting research participant autonomy
    Ø  Informed consent
    Ø  Ethical considerations for return of results
    Ø  Data privacy and donor confidentiality
    Ø  Data storage and consent
    Ø  Diversity in biobanking to promote equity.
    ·         It has been discussed that one-off consent or a broad consent for various research purposes may not suffice ethical and legal requirements. 
    ·         The extent to which the donor can share in the return of the research result. 
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
    Session 9. Governance in Bio Banking
    Low income countries have weak research capacity than high income countries and governance mechanisms for bio banks. Bio banks governance is also increasingly characterized by its deterritorialized, transnational or global character, which neither excludes the national character of projects nor a national rhetoric
    v  The Public Population Project in Genomics and Society
    v  The International Society for Biological and Environmental Repositories 
    v  The International Agency for Research on Cancer  
    This International Initiatives offered governance structures and practices and guidelines to promote the standardization of biobank. Bio banks try to adapt to the recommendations and guidelines which are accepted from human subject research.
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
    Session 10.Stem Cells
    Stem cells are undifferentiated cells found in multicellular organisms which divide through mitosis and differentiate into specialized cells. The two classical properties of stem cells which allow them to differentiate into almost any kind of body cells are self- renewal, and potency. Potential role which is present in alternative therapies, stem cells are a concept of extensive research in medical science. There are two major classes of stem cells: pluripotent that can become any cell in the adult body, and multipotent which are restricted to becoming a more limited population of cells. Two types of stem cells are identified which includes embryonic stem cells and adult stem cells. Embryonic stem cells are pluripotent and can differentiate into all cell types of the mature organism. In contrast, adult stem cells also called somatic stem cells which include hematopoietic stem cell, muscle stem cell, cardiac stem cell, neural stem cell and mesenchymal stem cell, must  have limited potency, and their  derivatives are generally populate only the tissue of residence.
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
    Session 11.Stem Cell Research
    Stem cell research place a foundation of basic scientific perception about the development of the whole organism from a unicellular entity or single cell itself. These cells are collected from few days old embryo, amniotic fluid or many other tissues, like, bone marrow and cultured in the laboratory under biological conditions.Stem cell research requires cellular tools and molecular tools to conform pluripotency or  determines downstream experiments in cells utility. Whether analyzing proliferation, protein levels, gene expression, or epigenetic profiles. Stem cell research is important to serve as a model for genetic disorders, such as DNA mechanisms or to design replacement therapies for chronic conditions.
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
    Session 12.Genome Editing
    The development of targeted genome editing technique using custom-engineered sequence-specific nucleases (including CRISPR/Cas9) allowed genetic changes with greater precision. This technique has a widespread application in the reprogramming of stem cells to study disease outcomes. The high evolution of these two techniques over years have paved a way for cellular interactions and regulation of transcription at a molecular level with great efficiency and flexibility.
    ·         CRISPR/Cas9 in genome editing
    ·         Genome editing for designer babies
    ·         DNA repair in stem cells
    ·         Generation of animal models by genome editing
    ·         Genome editing in stem cells done by targeting genetic disease
    ·         Future expectations of Stem Cell Research
    The extent of research in the field of stem cells has grown manifolds over the past few decades. Use of adult stem cells in various disease therapy  is the new approach with results in Regenerative medicine. With the emergence of new stem cell Pharmaceutical products for disease control, the therapeutic potential of stem cells and Tissue Regeneration seems boundless.
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
    Session 13.Stem Cell Transplantation
    World wide 1 million stem cells transplants have been performed. Today, with a stem cell transplant more than 70% cancer and non cancerous disease are treated. Among patients survival rates have been increased who received stem cell transplants from related and unrelated donors. Recent research done on 38,000 patients who are affected with serious blood cancer and diseases over a 12-year period shows the significant improvement in their survival rates from 48- 63 per cent. At present, cord blood has been utilized as an alternate of donor and achieved more than 2000 Cord blood Haematopoietic Stem Cell Transplants yearly. 
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation  
    Session 14.Stem Cell Banking
    Stem Cells can also be described as the building blocks of life. These are undifferentiated biological cells that can differentiate into specialized cells and can separate to produce more stem cells. In essence, a cell to be classified as a stem cell it need to possess the ability to self-renew and divide itself into two cells and stem cell  should be turn into cells that can change to different organs. The process of collecting stem cells from the umbilical cord after birth is the most better way of gathering stem cells because of the less amount of risk and costs. The umbilical cord blood is considered as one of the richest sources of hematopoietic stem cells, which possess the capability to form all types of blood cells – red cells, white cells and platelets.. The biobanking market is required to achieve USD 2.69 Billion by 2022 from USD 1.85 Billion of every 2017, at a CAGR of 7.8%.Advances in biobanking and the developing pattern of preserving cord blood stem cell of new-borns; government and private subsidizing to help Regenerative medication and the developing requirement for effective drug discovery and improvement. Tissue banking is of collecting, preparing and cryopreserving the cord tissue for  medical utilization.
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
    Session 15.Umbilical Cord Blood Banking and Donation
    Umbilical cord blood is highly enriched with Pluripotent stem cells which are considered life saving in later stages of life as they can treat a host of disorders. Cord blood stem cells are used to target blood disorders, immune deficiencies, and rare metabolic disorders, including leukaemia, Krabbe diseaseaplastic anaemia, non-Hodgkin’s lymphoma and Hodgkin’s lymphoma, sickle-cell anaemia and thalassemia, with least chances of rejection by the body. Cord blood preservation of new-born babies, also termed as, stem cell banking, in public or family banks is gaining a lot of awareness among people as it holds promise for future well-being.
    Global market for cord blood preservation
    Clinical application of stem cell banking
    Legal policies and regulations
    Ethical issues in cord blood banking.
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
    Session 16.Tissue Engineering
    Tissue engineering is a multi-disciplinary science involving the principles of cell biology, engineering and material sciences to replace or restore biological tissues which perform a specific function with a better framework. It is an act of combining the cells of construct, scaffold and growth factors into a functional tissue. The feasibility of bone-marrow derived mesenchyme stem cells, cardiac valves, auricular cartilage reconstruction, etc..
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
    Session 17.Tissue Preservation
    The International Biological Program was done from 1964 to 1974 before the rise of DNA sequence analysis over the Human Genome Diversity Project. A complex encounter between human geneticists and biological anthropologists was done featured by International Biological Program through Human Adaptability. In this way, the new access to technologies of cold storage, which would allow blood to be transported from the field to the lab and be stored for subsequent reanalysis, gave shape to this episode in Cold Warhuman biology and has ramified into our genomic age. ‘Latency’, a technical term initially used by cryobiologists to describe life in a state of suspended animation, can be extended as a concept for science studies scholars interested in techno-scientific efforts to manage the future. 
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
    Session 18.Tissue Preservation for Transplantation
    Towards goal there is a much progress, the final objective but still remains difficult to find. The current position of this review starts with the recognition of some tissues are required to comprise exhibit cells all the formal characteristics of life. For some tissues, the preservation of mechanical properties is crucial: for others it is not. For specific tissues methods these considerations are crucial: bone tendon and skin can provide grafts in the absence of living cells and this may even be true of cardiac valves: the crucial requirement here is that the mechanical properties remain intact. The damaging mechanisms are discussed, and it is concluded that the site of ice crystallization is crucial. Thus, developing tissue banking many methods are available
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
    Session 19.Tissue Engineering with Stem Cell Research
    Much research has been made in the field of tissue engineering, further research toward organ and tissue replacement is important.  Search of  multipotent or pluripotent stem cell in tissue engineering is an prominent concept. Applications which are associated with many controversies; is important to address the ethical, legal, and social issues early. Many technical questions are yet to be answered biologists, with the ultimate goal of functional tissue restoration. As more scientific knowledge will be gained from stem cell research, hopefully, some of the current ethical and technical concerns will be answered or removed in the future. 
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation
    Session 20.Tissue Engineering Legal and Ethical Issues
    Every research should have a virtuous base; tissue engineering too stands on some of ethical and legal issues. Ethical concerns and challenges should be scrutinized carefully. They are some ethical issues that bind the researchers to think before making a move 
    Ø  “Right to integrity of a person”
    Ø  “Protection of personal data”
    Ø  Solidarity
    Ø  “Private life and Right to information” 
     The applications of tissue engineering have some legal constraints. These implications must be the foundation for the ultimate success of tissue engineering.
    Biobanking Conferences | Conferences on Biobanking | Biobanking for Rare Diseases | Stem Cell | Stem Cell Congress | Tissue Engineering ConferencesTissue EngineeringGenomics Conferences | Tissue Preservation

    Market Analysis

    Current Status and Future Prospects
    High-quality bio specimens are using . The number of bio banks has increased worldwide. These utilization of bio specimens and its  data from bio banks enables cost-effective and fast retrospective studies. At the same time, it enables collection of bio specimen for prospective studies with high-quality samples following standardized processes and work flows for handling, processing, and storage. Based on standardized processes, bio specimens are collected and stored which gives reduction of sample quality-related products in biomedical research.




    Global Market Overview of Bio banking
    Global biobanking market was valued at $47,062 million in 2017, and is estimated to reach $68,084 million by 2025, with a CAGR of 4.6% from 2018 to 2025. Bio banking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research. The major factors that drive the growth of the global biobanking market includerise in funding support by private & government organizations. Furthermore,increased incidence of chronic disease further prompted the market growth.However, ethical and legal issues related to biobanking restrict the market growth.
     Specimen  is segmented by global bio banking market, It is a type of bio bank, ownership, and region. The market is categorized into blood products, solid tissue, cell lines, and others based on specimen type. On the basis of ownership, it is divided into national/regional agencies, nonprofit organization, university, and private. The applications covered in the study include therapeutic and research. Depending on type of bio bank, the market is bifurcated into population and disease-oriented bio bank .Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

    Increase in Funding Support for Bio banking
    The samples from bio banks are used for various purposes such as research,therapeutics, clinical trials, and drug development. This has led to increasing funding by many non-profit and government organizations for the establishment of more public storage banks. For instance, more than 200 clinical trials are funded by the National Institutes of Health and are being carried out in the U.S. alone. In addition, in October 2017, National Institutes of Health granted$2.1 million to the UK ME/CFS Bio bank, which represents a huge investment in biomedical research. 

    Stem Cell Bio banking
    Stem cell have some good therapeutics as well as biotechnological effects and they also used for replacing damaged and even to deliver the proteins by using cells specific stem cell. Past 10 years, umbilical cord blood played a very vital role in rescuing patients from inborn errors and it has greater advantages in they not depend on the human leukocyte antigen, graft rejection is less  in number. The umbilical cord blood transplant was first experimented in a five-year-old kid who was suffered from Fanconi anemia has been cured by allogeneic host. Recently, umbilical cord blood is the major stem cell source where 2000 Cord blood stem cell transplants are done annually. In this year,about 35,000 patients umbilical cord blood has been received in the world and India which has a birth rate of 26 million births/ year shows the largest collector of umbilical cord blood in the world.
    Now a day, public umbilical cord blood banks are growing vastly for the potential clinical use, where today it reached around 142 public banks and 25 private banks which are actively involved in sample collecting,preserving and testing for future use in the field of stem cell and therapeutics.
    The very first operations have been achieved with ISO 13485 and certified with GMP, GLP and GCP in the consecutive operations. Based on the cancer stages and severity of the diseases, around 30,000 units of blood stem cell are distributed all over the world to treat from children to adults. The more transplant has performed in US, where 5000 umbilical cord blood transplants has been done in 2009.

    Tissue Engineering Prospects
    The worldwide tissue engineering business sector estimates around USD 5 billion in 2016 and is expected to develop in the rate. Tissue engineering is having a vast application in tissue repair,. The need of regenerative medicine in the current era is to have a quality life, healthy and healing process.
    Based on the  research of Regenerative Medicine Foundation,there are nearly 1.3 million patients were suspected to breast cancer and 1.5 million individuals of Parkinson's infection. The people who needed of bone implants are rising due to the chronic diseases including trauma cases.
    3D tissue engineering has been developing quickly and the advancements in this field as organ-on-a-chip technologies and use of 3 D bio-printers. NIH gave look into financing worth USD 445 million to human non-embryonic undeveloped cell research and USD 180 million to human embryonic stem cell inquire about. Government is spending lots of funding in the stemcells and regenerative medicine

    Why Abu Dhabi?
    The world's largest hand-loomed carpet, the fastest roller coaster, the highest high tea, the tower with the greatest lean, the largest cluster of cultural buildings of the 21st century, Abu Dhabi is the capital and the second most populous city of the United Arab Emirates and also capital of the Emirate of Abu Dhabi, the largest of the UAE's seven emirates. United Arab Emirates is a fast-growing economy: in 2006 the per capita income grew by 9%, providing a GDP per capita of $49,700. The UAE Healthy Future study aims to determine how genetics and environmental factors interact to affect the health and well-being of Emiratis and provide required biological samples, to researchers at the center. Abu Dhabi being one of the richest cities in the world, it attracts a wide range of tourists to visit the sights like Sheikh Zayed Grand Mosque, Emirates Palace, Louvre Abu Dhabi and Umm Al Emirate Park. Abu Dhabi weather in December is very warm and sunny with slightest chances of rainfall making the stay convenient.

    Top major Associations around the World
    FINNGEN bio banks, Finland
    Canadian Partnership for Tomorrow Project Bio bank, Canada
    China Kadoorie Bio bank, China
    The International Agency For Research On Cancer (IARC) Bio bank (IBB)
    Shanghai Zhangjiang Bio bank, China
    Sub-Saharan African Regional Bio specimen Repository (SSARBR), Cape Town, South Africa
    Swiss Bio banking Platform, Lausanne, Switzerland
    Ukraine Association of Bio bank, Kharkiv, Ukraine
    University Bio bank Limburg, Hasselt, Belgium

    Organizing Committee
    OCM Member
    Dr. Joel I. Osorio
    RegenerAge Clinic
    Mexico, Mexico
    OCM Member
    Zeliha Selamoglu
    Omer Halisdemir University
    Nigde, Turkey
    OCM Member
    Ian James Martins
    Edith Cowan University
    Queensland, Australia
    OCM Member
    Charles W. Wang
    Shanghai Jiao Tong University, China
    Shangai, China
    OCM Member
    H.P Puttaraju
    Bangalore University
    Bengaluru, India
    OCM Member
    Rosa Lelyana
    Diponegoro University
    Sumatra, Indonesia
    OCM Member
    Sergey Suchkov
    Russian Academy of Sciences, Saratov
    Moscow, Russia
    OCM Member
    Segundo Mesa Castillo
    Psychiatric Hospital of Havana, Cuba
    Havana, Cuba
    OCM Member
    Matteo Bovolenta
    University of Ferrara
    Bologna, Italy
    OCM Member
    Dr. Khalid Shah
    Director, Center for Stem Cell Therapeutics and Imaging
    Harvard Medical School
    Boston, USA
    OCM Member
    Mr. Alejandro De la Parra Solomon
    CEO
    WAMS(The World Academy of Medical Sciences)
    Mexico, Mexico
    OCM Member
    Murugan Ramalingam
    Professor
    Christian Medical College
    MADURAI, India
    OCM Member
    Dr. Alireza Heidari
    President
    American International Standards Institute (AISI)
    New York, USA
    OCM Member
    Giulio (Filippo, Giacomo) Tarro
    President, Biology, Virology and Cancer Research
    Foundation T. & L. de Beaumont Bonelli for cancer research
    Naples, Italy
    OCM Member
    Dr.Ahmed G Hegazi
    Professor, Microbiology and Immunology
    National Research Center
    Cairo, Egypt
    OCM Member
    Dr.Yukio Yoneda
    Professor Emeritus, Section of Prophylactic Pharmacology
    Kanazawa University
    Tokyo, Japan
    Renowned Speakers

    To Collaborate Scientific Professionals around the World

    Conference Date December 9-10, 2019
    Speaker Oppurtunity Day 1 Day 2
    Poster Oppurtunity Available
    e-Poster Oppurtunity Available
    Sponsorship Opportunities Click here for Sponsorship Opportunities
    Venue
    &
    Hospitality

    Join The Discussion

    Allied Academies Global Conference Directory

    Mail us at

    For Program Enquiry
    biobanking@alliedglobalevents.com
    Sponsors/Exhibitors/Advertisers
    sponsor@alliedglobalevents.com
    General enquiry
    biobanking@alliedmeeting.com
    More details about sponsorship:sponsors@alliedacademies.com

    Terms and Conditions

    Responsibility

    The organizers holds no responsibilities or liabilities of the personal articles of attendees at the venue against any kind of theft, lost, damage, due to any reason whatsoever. Delegates are entirely responsible for the safety of their own belongings.

    Insurance

    No insurance, of any kind, is included along with the registration in any of the events of the organization.

    Transportation

    Please note that transportation and parking is the responsibility of the registrant, Allied Academies will not be liable for any actions howsoever related to transportation and parking.

    Press/Media

    Press permission must be obtained from Allied Academies Conference Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party nonprofit organization and this conference is not associated with any commercial meeting company.

     Requesting an Invitation Letter

    For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference after payment of complete registration fee. Once registration is complete, please contact biobanking@alliedevents.org  to request for a personalized letter of invitation, if not received until one month before the scheduled date of event.

    All the bank charges applicable during refund will be deducted from the account of participant.

    Cancellation Policy

    All cancellations or modifications of registration must be made in writing to finance@alliedacademies.com

    If, due to any reason, Allied academies postpone an event on the scheduled date, the participant is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.

    Postponement of event

    If, due to any reason, Allied academies postpone an event and the participant is unable or unwilling to attend the conference on rescheduled dates, he/she is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.

     Transfer of registration

    All registrations, after payment of complete registration fee, are transferable to other persons from the same organization, if in case the person is unable to attend the event. Request for transfer of registration must be made by the registered person in writing to finance@alliedacademies.com. Details must include the full name of replaced new registrant, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

    Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of conferences.

    However, Registration cannot be transferred if intimated within 14 days of respective conference.

    The transferred registrations will not be eligible for Refund.

    This cancellation policy was last updated on April 04, 2015.

    Visa Information

    Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

    Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

    Important note for failed visa applications: Visa issues are not covered under the cancellation policy of Allied academies, including the inability to obtain a visa.

     

    Refund Policy:

    If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund policies apply:

    Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overhead charges, following Refund Policy Orders are available:

    • Before 60 days of the conference: Eligible for Full Refund after deduction of $100 towards service Fee.
    • Within 60-30 days of Conference: Eligible for 50% of payment Refund
    • Within 30 days of Conference: Not eligible for Refund
    • E-Poster Payments will not be refunded.

    Accommodation Cancellation Policy:

    Accommodation Service Providers (Hotels) have their own cancellation policies which are applicable when cancellations are made less than 30 days prior to arrival. If in case the registrant wishes to cancel or amend the accommodation, he/ she is expected to inform the organizing authorities on a prior basis. Allied academies will advise the registrant to ensure complete awareness about the cancellation policy of your accommodation provider, prior to cancellation or modification of their booking.

    Authorization Policy

    Copyright © 2019-2020 Allied Academies, All Rights Reserved.